Functional HIV-1 specific IgA antibodies in HIV-1 exposed, persistently IgG seronegative female sex workers (Q57997576)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595287%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

Functional HIV-1 specific IgA antibodies in HIV-1 exposed, persistently IgG seronegative female sex workers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595287%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595287%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Mario Clerici

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595287%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Rupert Kaul

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595287%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1

K Broliden

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595287%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

C Devito

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595287%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

P Kiama

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595287%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

J Kimani

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595287%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

D Trabbatoni

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595287%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

J J Bwayo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595287%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

F Plummer

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595287%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 November 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595287%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595287%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595287%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595287%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

29-36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595287%20AND%20SRC:MED&resulttype=core&format=json

Soluble HIV suppressive factors: more than one Holy Grail?

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

Immune responses in HIV-exposed seronegatives: have they repelled the virus?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

Human immunodeficiency virus type 1 (HIV-1)-seronegative injection drug users at risk for HIV exposure have antibodies to HLA class I antigens and T cells specific for HIV envelope

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

Factors contributing to the lack of human immunodeficiency virus type 1 (HIV-1) transmission in HIV-1-discordant partners.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

Protection against human immunodeficiency virus type 1 infection in persons with repeated exposure: evidence for T cell immunity in the absence of inherited CCR5 coreceptor defects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

Resistance to HIV-1 infection among highly exposed sex workers in Nairobi: what mediates protection and why does it develop?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

Mechanisms of HIV/SIV mucosal transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

A rational basis for mucosal vaccination against HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

HIV-1-specific mucosal CD8+ lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

Interaction of antigens and antibodies at mucosal surfaces

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

Endocytosis in filter-grown Madin-Darby canine kidney cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

HIV-1-specific immunity in persistently seronegative individuals at high risk for HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

Resistance to HIV infection: the genes are only part of the solution

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand. Chiang Mai HEPS Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

HIV-1-specific cellular immune responses among HIV-1-resistant sex workers

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

HIV type 1 resistance in Kenyan sex workers is not associated with altered cellular susceptibility to HIV type 1 infection or enhanced beta-chemokine production

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

CCR5-reactive antibodies in seronegative partners of HIV-seropositive individuals down-modulate surface CCR5 in vivo and neutralize the infectivity of R5 strains of HIV-1 In vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

Anti-CD4 Antibodies in Exposed Seronegative Adults and in Newborns of HIV Type 1-Seropositive Mothers: A Follow-up Study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

HIV infection among lower socioeconomic strata prostitutes in Nairobi

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

A method of obtaining, processing, and analyzing human intestinal secretions for antibody content

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

Absence of specific mucosal antibody responses in HIV-exposed uninfected sex workers from the Gambia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

Progress in the development of an HIV-1 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

Antibody neutralization of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

Neutralizing Antibody Responses to Human Immunodeficiency Virus Type 1 in Primary Infection and Long‐Term‐Nonprogressive Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

Neutralizing monoclonal antibodies block human immunodeficiency virus type 1 infection of dendritic cells and transmission to T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

Recognition of enteropathogenic Escherichia coli virulence determinants by human colostrum and serum antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

Human immunodeficiency virus (HIV)-specific IgA and HIV neutralizing activity in the serum of exposed seronegative partners of HIV-seropositive persons

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

Cellular immune factors associated with mother-to-infant transmission of HIV

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

A vaccine for HIV type 1: The antibody perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900263-2

7 January 2021

10.1016/S0165-2478(01)00263-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595287%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference